U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 209613

Expand all

TERIFLUNOMIDE (TERIFLUNOMIDE)
7MG
Marketing Status: Prescription
Active Ingredient: TERIFLUNOMIDE
Proprietary Name: TERIFLUNOMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 7MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209613
Product Number: 001
Approval Date: Sep 28, 2018
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS CO GMBH
Marketing Status:  Prescription
Patent and Exclusivity Information
TERIFLUNOMIDE (TERIFLUNOMIDE)
14MG
Marketing Status: Prescription
Active Ingredient: TERIFLUNOMIDE
Proprietary Name: TERIFLUNOMIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 14MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A209613
Product Number: 002
Approval Date: Sep 28, 2018
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS CO GMBH
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top